Latest Director Loans News

Genmin Limited has made significant progress on its Baniaka iron ore project in Gabon, with PowerChina submitting competitive engineering and construction proposals and the company securing A$15 million in director-related loans during the quarter.

Pathkey.AI reports strong validation of its TrialKey AI platform’s predictive accuracy and announces key leadership changes as it advances toward commercial scale.

Genmin Limited’s non-executive directors have increased their loan funding by A$0.4 million and taken over a A$3 million loan from its largest shareholder, providing immediate working capital for the Baniaka iron ore project in Gabon.

Vectus Biosystems has signed a binding agreement to sell its VB4-P5 renal fibrosis compound to Canadian biotech XORTX Therapeutics, while actively pursuing licensing opportunities for its lead drug VB0004 and others, particularly in China.

Cullen Resources has secured key tenements and begun drilling at its Yardilla Gold Project while completing a A$1.5 million sale of its Wyloo Iron Ore Royalty, bolstering its exploration funding.

Zelira Therapeutics has made significant progress in its HOPE 1 clinical trial program, completing a key FDA submission and securing a $650,000 non-dilutive R&D loan facility to support ongoing development and working capital needs.

Mt Malcolm Mines NL has announced a pro-rata renounceable entitlement issue to raise up to $2.33 million, partially underwritten by Mahe Capital Pty Ltd. The capital raise aims to fund exploration drilling, repay director loans, and support working capital.

Mt Malcolm Mines NL has announced a $2.3 million renounceable rights issue priced at 1.5 cents per share, aiming to fund exploration and development at its Malcolm Gold Project while strengthening its financial position.

Canterbury Resources is on the cusp of completing a pivotal scoping study for its Briggs Copper Project, while deep drilling advances to unlock higher-grade mineralisation. The company also moves forward with new exploration initiatives and a share purchase plan to bolster funding.

My Rewards International Limited has announced a pro-rata entitlement offer aiming to raise up to $4.1 million, a key step toward meeting ASX reinstatement conditions after a prolonged trading suspension. The offer includes a debt conversion proposal and is partially underwritten by major shareholders.

Cobram Estate Olives Limited has launched a $185 million capital raising to fund a major expansion of its vertically integrated olive oil operations in California, aiming to become the largest olive farmer in the US.

Eden Innovations Ltd reported a 21% revenue increase driven by global sales growth, yet its net loss widened significantly due to prior year asset revaluations and ongoing operational costs. The company is undertaking major financial restructuring including a share consolidation and rights issue to stabilize its balance sheet.